Zacks Research Brokers Cut Earnings Estimates for Teleflex

Teleflex Incorporated (NYSE:TFX) – Equities researchers at Zacks Research decreased their FY2026 earnings per share (EPS) estimates for shares of Teleflex in a note issued to investors on Monday, December 15th. Zacks Research analyst Team now anticipates that the medical technology company will earn $14.90 per share for the year, down from their previous estimate of $14.92. Zacks Research currently has a “Hold” rating on the stock. The consensus estimate for Teleflex’s current full-year earnings is $13.98 per share. Zacks Research also issued estimates for Teleflex’s Q2 2027 earnings at $4.08 EPS and FY2027 earnings at $16.36 EPS.

TFX has been the subject of a number of other research reports. Wall Street Zen cut shares of Teleflex from a “buy” rating to a “hold” rating in a research report on Saturday, November 15th. Truist Financial raised their price objective on shares of Teleflex from $120.00 to $135.00 and gave the stock a “hold” rating in a report on Thursday. Royal Bank Of Canada reiterated a “sector perform” rating and issued a $135.00 target price on shares of Teleflex in a research note on Wednesday. Wells Fargo & Company increased their price target on Teleflex from $114.00 to $139.00 and gave the stock an “equal weight” rating in a research report on Wednesday, December 10th. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Teleflex in a report on Monday. One analyst has rated the stock with a Buy rating, nine have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, Teleflex currently has an average rating of “Reduce” and a consensus price target of $142.43.

Teleflex Stock Down 2.2%

Shares of NYSE TFX opened at $121.73 on Thursday. Teleflex has a 52-week low of $102.58 and a 52-week high of $185.94. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.53 and a current ratio of 2.57. The business has a fifty day moving average of $120.13 and a two-hundred day moving average of $121.03. The stock has a market cap of $5.38 billion, a PE ratio of -16.56, a PEG ratio of 1.48 and a beta of 0.95.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, November 6th. The medical technology company reported $3.67 EPS for the quarter, topping the consensus estimate of $3.38 by $0.29. Teleflex had a positive return on equity of 15.64% and a negative net margin of 10.28%.The business had revenue of $892.90 million during the quarter, compared to the consensus estimate of $892.79 million. During the same quarter last year, the company earned $3.49 EPS. Teleflex’s revenue was up 19.4% on a year-over-year basis. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS.

Teleflex Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, December 15th. Shareholders of record on Friday, November 14th were issued a dividend of $0.34 per share. The ex-dividend date of this dividend was Friday, November 14th. This represents a $1.36 annualized dividend and a yield of 1.1%. Teleflex’s dividend payout ratio is currently -18.50%.

Institutional Investors Weigh In On Teleflex

Hedge funds and other institutional investors have recently made changes to their positions in the company. Thurston Springer Miller Herd & Titak Inc. lifted its stake in shares of Teleflex by 242.9% during the second quarter. Thurston Springer Miller Herd & Titak Inc. now owns 216 shares of the medical technology company’s stock valued at $26,000 after acquiring an additional 153 shares during the period. MassMutual Private Wealth & Trust FSB raised its holdings in Teleflex by 57.9% during the 3rd quarter. MassMutual Private Wealth & Trust FSB now owns 210 shares of the medical technology company’s stock worth $26,000 after purchasing an additional 77 shares during the last quarter. Brooklyn Investment Group lifted its position in Teleflex by 258.6% during the 1st quarter. Brooklyn Investment Group now owns 208 shares of the medical technology company’s stock valued at $29,000 after purchasing an additional 150 shares during the period. Hantz Financial Services Inc. boosted its stake in shares of Teleflex by 248.8% in the 3rd quarter. Hantz Financial Services Inc. now owns 279 shares of the medical technology company’s stock valued at $34,000 after purchasing an additional 199 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. acquired a new stake in shares of Teleflex during the 3rd quarter worth approximately $35,000. 95.62% of the stock is owned by institutional investors and hedge funds.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.